ATE490469T1 - Beurteilung des skelettwachstums unter verwendung von messungen von nt-cnp-peptiden - Google Patents
Beurteilung des skelettwachstums unter verwendung von messungen von nt-cnp-peptidenInfo
- Publication number
- ATE490469T1 ATE490469T1 AT04748820T AT04748820T ATE490469T1 AT E490469 T1 ATE490469 T1 AT E490469T1 AT 04748820 T AT04748820 T AT 04748820T AT 04748820 T AT04748820 T AT 04748820T AT E490469 T1 ATE490469 T1 AT E490469T1
- Authority
- AT
- Austria
- Prior art keywords
- growth
- cnp
- plasma
- assessment
- provides
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ52652603 | 2003-06-17 | ||
PCT/NZ2004/000125 WO2004111653A1 (en) | 2003-06-17 | 2004-06-17 | Assessment of skeletal growth using measurements of nt-cnp peptides |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE490469T1 true ATE490469T1 (de) | 2010-12-15 |
Family
ID=33550523
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04748820T ATE490469T1 (de) | 2003-06-17 | 2004-06-17 | Beurteilung des skelettwachstums unter verwendung von messungen von nt-cnp-peptiden |
Country Status (7)
Country | Link |
---|---|
US (1) | US7919255B2 (de) |
EP (1) | EP1644740B1 (de) |
AT (1) | ATE490469T1 (de) |
CA (1) | CA2570398C (de) |
DE (1) | DE602004030342D1 (de) |
DK (1) | DK1644740T3 (de) |
WO (1) | WO2004111653A1 (de) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070037208A1 (en) * | 2003-05-29 | 2007-02-15 | Foote Robert S | Method for detecting cardiac ischemia via changes in b-natriuretic peptide levels |
DK3404102T3 (da) | 2004-04-21 | 2021-09-06 | Alexion Pharma Inc | Knogletilførselskonjugater og fremgangsmåde til anvendelse heraf til målretning af proteiner mod knogle |
US8735142B2 (en) * | 2005-08-16 | 2014-05-27 | Chipotle Business Group, Inc. | Systems and methods for immunosorbent assays for single and multiple analytes |
US7767404B2 (en) * | 2005-08-16 | 2010-08-03 | Chipotle Business Group, Inc. | Apparatus and method for single-step immunosorbent assay for single and multiple analytes |
EP3175863B1 (de) | 2009-05-20 | 2021-12-01 | BioMarin Pharmaceutical Inc. | Varianten des natriuretischen peptids typ c |
US9266939B2 (en) | 2010-12-27 | 2016-02-23 | Alexion Pharmaceuticals, Inc. | Compositions comprising natriuretic peptides and methods of use thereof |
US10052366B2 (en) | 2012-05-21 | 2018-08-21 | Alexion Pharmaceuticsl, Inc. | Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof |
EP2883060B1 (de) * | 2012-08-13 | 2018-03-21 | Otago Innovation Limited | Nt-procnp als biomarker für gefässerkrankungen und schwangerschaftskomplikationen |
US10822596B2 (en) | 2014-07-11 | 2020-11-03 | Alexion Pharmaceuticals, Inc. | Compositions and methods for treating craniosynostosis |
JP6787894B2 (ja) | 2014-12-05 | 2020-11-18 | アレクシオン ファーマシューティカルズ, インコーポレイテッド | 組換えアルカリホスファターゼを用いた発作の処置 |
CA2973883A1 (en) | 2015-01-28 | 2016-08-04 | Alexion Pharmaceuticals, Inc. | Methods of treating a subject with an alkaline phosphatase deficiency |
CN108350440A (zh) | 2015-08-17 | 2018-07-31 | 阿雷克森制药公司 | 碱性磷酸酯的制造 |
EP3355904A4 (de) | 2015-09-28 | 2019-06-12 | Alexion Pharmaceuticals, Inc. | Identifizierung wirksamer dosierungsschemata für gewebeunspezifische alkalische phosphatase-enzymersatztherapie von hypophosphatasie |
WO2017074466A1 (en) | 2015-10-30 | 2017-05-04 | Alexion Pharmaceuticals, Inc. | Methods for treating craniosynostosis in a patient |
US11065306B2 (en) | 2016-03-08 | 2021-07-20 | Alexion Pharmaceuticals, Inc. | Methods for treating hypophosphatasia in children |
US10898549B2 (en) | 2016-04-01 | 2021-01-26 | Alexion Pharmaceuticals, Inc. | Methods for treating hypophosphatasia in adolescents and adults |
MX2018011833A (es) | 2016-04-01 | 2019-02-13 | Alexion Pharma Inc | Tratamiento para la debilidad muscular con fosfatasas alcalinas. |
WO2017214130A1 (en) | 2016-06-06 | 2017-12-14 | Alexion Pharmaceuticals, Inc. | Metal impact on manufacturing of alkaline phosphatases |
US20170363620A1 (en) | 2016-06-17 | 2017-12-21 | Abbott Laboratories | BIOMARKERS TO PREDICT NEW ONSET HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFpEF) |
EP3500289A4 (de) | 2016-08-18 | 2020-05-06 | Alexion Pharmaceuticals, Inc. | Verfahren zur behandlung von tracheobronchomalazie |
CA3057502A1 (en) | 2017-03-31 | 2018-10-04 | Alexion Pharmaceuticals, Inc. | Methods for treating hypophosphatasia (hpp) in adults and adolescents |
JP2021519590A (ja) | 2018-03-30 | 2021-08-12 | アレクシオン ファーマシューティカルズ, インコーポレイテッド | 糖タンパク質の製造 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT407580B (de) * | 1999-08-20 | 2001-04-25 | Biomedica Gmbh | Indikatorpeptid zur diagnose und/oder vorhersage von cardiovasculären und/oder endothelialen erkrankungen, antikörperzusammensetzung und immunoassay |
US20030219734A1 (en) * | 2001-04-13 | 2003-11-27 | Biosite Incorporated | Polypeptides related to natriuretic peptides and methods of their identification and use |
-
2004
- 2004-06-17 US US10/561,119 patent/US7919255B2/en not_active Expired - Fee Related
- 2004-06-17 DK DK04748820.0T patent/DK1644740T3/da active
- 2004-06-17 DE DE602004030342T patent/DE602004030342D1/de not_active Expired - Lifetime
- 2004-06-17 CA CA2570398A patent/CA2570398C/en not_active Expired - Fee Related
- 2004-06-17 AT AT04748820T patent/ATE490469T1/de not_active IP Right Cessation
- 2004-06-17 WO PCT/NZ2004/000125 patent/WO2004111653A1/en active Application Filing
- 2004-06-17 EP EP04748820A patent/EP1644740B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1644740A1 (de) | 2006-04-12 |
DE602004030342D1 (de) | 2011-01-13 |
WO2004111653A1 (en) | 2004-12-23 |
US20070292966A1 (en) | 2007-12-20 |
CA2570398A1 (en) | 2004-12-23 |
EP1644740B1 (de) | 2010-12-01 |
US7919255B2 (en) | 2011-04-05 |
EP1644740A4 (de) | 2007-12-12 |
CA2570398C (en) | 2020-05-12 |
DK1644740T3 (da) | 2011-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE490469T1 (de) | Beurteilung des skelettwachstums unter verwendung von messungen von nt-cnp-peptiden | |
US7344626B2 (en) | Method and apparatus for detection of abnormal traces during electrochemical analyte detection | |
Kumari et al. | A nonlinear relationship of generalized and central obesity with diurnal cortisol secretion in the Whitehall II study | |
NO20063816L (no) | Systemer og fremgangsmater for avfoling av blodglykose | |
Hosoi et al. | Quantitative analysis of calcium-dependent vesicle recruitment and its functional role at the calyx of Held synapse | |
Sargent et al. | Rapid vesicular release, quantal variability, and spillover contribute to the precision and reliability of transmission at a glomerular synapse | |
Shetty et al. | Developmental validation of a point-of-care, salivary α-amylase biosensor | |
Daniels et al. | Serial measurement of N-terminal pro–B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA) | |
CA2535833A1 (en) | Method and apparatus for assay of electrochemical properties | |
NO20045129L (no) | System og fremgangsmate for maling av blodglukose | |
CN102770763B (zh) | 电化学分析中的电容检测 | |
EP1664783A4 (de) | Schnelltest für glykiertes albumin | |
EP2042865A3 (de) | Systeme und Verfahren zur Unterscheidung zwischen einer Kontrolllösung und einer physiologischen Probe | |
RU2012103000A (ru) | Способ и система для тестирования аналита | |
CN104838258A (zh) | 用于血细胞比容校正的方法和为此适配的血糖仪 | |
CN104582568A (zh) | 用于检测使用过且变干的传感器的***和方法 | |
MX340856B (es) | Sistema y metodos que determinan concentracion de analito utilizando amperometria resuelta en tiempo. | |
MXPA02010106A (es) | Determinacion de suficiencia de volumen de muestra en dispositivos biosensores. | |
TW200413718A (en) | Method and system for determining the acceptability of signal data collected from a prothrombin time test strip | |
Kang et al. | Reliable clinical serum analysis with reusable electrochemical sensor: Toward point-of-care measurement of the antipsychotic medication clozapine | |
JP2000275163A5 (ja) | 粒子分析装置および自動粒子分析方法 | |
Mason et al. | The interpretation of current-clamp recordings in the cell-attached patch-clamp configuration | |
MX2012007009A (es) | Método para diagnosticar un tumor maligno. | |
ATE370414T1 (de) | Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs | |
Bordey et al. | Chemokine modulation of high‐conductance Ca2+‐sensitive K+ currents in microglia from human hippocampi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |